Upgrade to SI Premium - Free Trial

Esperion Therapeutics (ESPR) PT Lowered to $73 at Citi

May 28, 2019 6:21 AM
Citi analyst Joel Beatty lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles